Cardiology

Lipid-lowering drugs save lives, but use decreasing

Lipid-lowering drugs for primary prevention are associated with a significant survival benefit, but use has decreased over time, according to a study published online Nov. 16 in Circulation.

Cardiology

Antibodies linked to heart attacks

Levels of antiphospholipid antibodies, which are associated with rheumatic diseases, are also elevated in myocardial infarction without any autoimmune co-morbidity, a study from Karolinska Institutet in Sweden published in ...

Cardiology

Treating, preventing heart attacks with human tissue models

A heart attack, or myocardial infarction, is one of the leading causes of mortality worldwide, resulting in 18 million deaths per year. These numbers are expected to increase in coming years because of cardiovascular complications ...

Cardiology

Results of the REMEDEE trial reported at TCT 2011

A randomized comparison of a dual therapy stent – which combines low-dose sirolimus delivery from an abluminal biodegradable polymer matrix with a covalently bound anti-CD34 antibody layer – with a paclitaxel-eluting ...

Cardiology

~40 percent undergo stress testing after PCI in VA system

(HealthDay)—In the Veterans Affairs (VA) health care system, nearly 40 percent of patients undergo stress testing in the two years following percutaneous coronary intervention (PCI), according to a study published online ...

page 22 from 40